eClinical Solutions Market Worth 7.61 Billion USD by 2022

Wednesday, April 19, 2017 Research News
Email Print This Page Comment bookmark
Font : A-A+

PUNE, India, April 19, 2017 /PRNewswire/ --

According to a new market research report "eClinical Solutions Market by Product (CDMS, EDC, CTMS, eCOA, Analytics, RTMS, eTMF, Safety), Delivery Mode (On-Demand, On-premise, Cloud-based), Clinical Trial Phases, End User (Pharma/Biopharma Companies, CROs, Hospitals) - Global Forecast to 2022

", published by MarketsandMarkets™, this report studies the market over the forecast period of 2017 to 2022. The market is expected to grow to USD 7.61 Billion by 2022, at CAGR of 12.4% during the forecast period.


(Logo: )

Browse 72 market data Tables and 40 Figures spread through 163 Pages and in-depth TOC on "eClinical Solutions Market"

Early buyers will receive 10% customization on this report. 

The report analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the World (RoW).

Increasing operational costs and regulatory requirements associated with clinical research studies, government grants to support clinical trials, and increasing R&D expenditure by pharma-biotech companies with augmented IT budgets for drug development are some of the major driving factors for the global eClinical solutions market.

The growing number of clinical research activities in emerging Asia-Pacific countries and a shift from manual data interpretation to real-time data analysis during clinical studies also offer high growth opportunities for market players. On the other hand, high implementation costs associated with eClinical solutions is restricting the growth of this market.

Based on the type of product, the global eClinical solutions market is divided into ten segments, namely, electronic data capture (EDC) and clinical data management systems (CDMS), clinical trial management systems (CTMS), clinical analytics platform, randomization & trial supply management systems (RTMS), clinical data integration platforms, electronic clinical outcome assessment (eCOA), safety solutions, electronic trail master files (eTMF), regulatory information management solutions (RIMS), and others (coding systems, institutional review board (IRB) systems, and core lab integration solutions).

Speak To Analyst:

The eClinical solutions market has also been segmented on the basis of delivery mode into web-hosted (on-demand), licensed enterprise (on-premise), and cloud-based (SaaS) solutions. Based on the clinical trial phase, the market is divided into four segments phase I, phase II, phase II, and phase IV. On the basis of end users, the global eClinical solutions market has been segmented into pharmaceutical and biopharmaceutical companies, contract research organizations, consulting service companies, medical device manufacturers, hospitals, and academic research institutions.

North America was the largest regional segment in the global eClinical solutions market in 2016, followed by Europe. The Asia-Pacific market is expected to grow at the highest CAGR from 2017 to 2022. A number of factors, including increasing government funding to support clinical trials, presence of less stringent regulatory guidelines compared to developed nations, availability of a large patient base and faster patient recruitment for clinical trials, and growing number of pharmaceutical companies and CROs are stimulating the growth of the eClinical solutions market in the Asia-Pacific region.

Download PDF Brochure@

Oracle Corporation (U.S.), Medidata Solutions, Inc. (U.S.) PAREXEL International Corporation (U.S.), BioClinica, Inc. (U.S.), CRF Health (U.S.), DATATRAK International, Inc. (U.S.), ERT (U.S.), Merge Healthcare Incorporated (U.S.), OmniComm Systems, Inc. (U.S.), MaxisIT Inc. (U.S.), Bio-Optronics, Inc. (U.S.), and eClinical Solutions, Inc. (U.S.) are some key players operating in the global eClinical solutions market.

Browse Related Reports: 

Healthcare Analytics/ Medical Analytics Market by Application (Clinical, RCM, Claim, Fraud, Supply Chain, HR, PHM), Type (Prescriptive), Component (Service, Software), Delivery (On-premise, Cloud), End User (Hospital, Payer, ACO, TPA) - Forecasts to 2021

Bioinformatics Market by Sector (Molecular Medicine, Agriculture, Forensic, Animal, Research & Gene Therapy), Product (Sequencing Platforms, Knowledge Management & Data Analysis) & Application (Genomics, Proteomics & Metabolomics) - Global Forecast to 2021

About MarketsandMarkets: 

MarketsandMarkets™ is the largest market research firm worldwide in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets™ are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact: Mr. Rohan MarketsandMarkets™ 701 Pike Street Suite 2175, Seattle, WA 98101, United States Telephone No: +1-888-600-6441. Email:

Visit our Blog @

Connect with us on LinkedIn @

SOURCE MarketsandMarkets

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store